Interaction of Presynaptically Toxic Phospholipases A₂ with Membrane Receptors and Other Binding Sites

References

• Tu A. T. Handbook of Natural ToxinsReptile Venoms and Toxins. Marcel Dekker, New York 1991; Vol. 5
   Google Scholar
• Shier W T., Mebs D. Handbook of Toxinology. Marcel Dekker, New York 1990
   Google Scholar
• Harvey A. L. Presynaptic effects of toxins. Int. Rev. Neurobiol. 1990; 32: 201–239
   Google Scholar
• Rosenberg P. Phospholipases. Handbook of Toxinology, W. T. Shier, D. Mebs. Marcel Dekker, New York 1990; 67
   Google Scholar
• Hawgood B., Bon C. Snake Venom Presynaptic Toxins. Handbook of Natural Toxins, Vol. 5, Reptile Venoms and Toxins, A. T. Tu. Marcel Dekker, New York 1991; 3
   Google Scholar
• Davidson F. F., Dennis E. A. Structure, Function, and Mode of Action of Snake Venom and Other Phospholipases A2. Handbook of Natural Toxins, Vol. 5, Reptile Venoms and Toxins, A. T. Tu. Marcel Dekker, New York 1991; 107
   Google Scholar
• Longenecke C. L. Effects of Snake Venoms on Blood Platetets. Handbook of Natural Toxins, Vol. 5, Reptile Venoms and Toxins, A. T. Tu. Marcel Dekker, New York 1991; 189
   Google Scholar
• Tu A. T. Tissue Damaging Effects by Snake Venoms: Hemorrhage and Myonecrosis. Handbook of Natural Toxins, Vol. 5, Reptile Venoms and Toxins, A. T. Tu. Marcel Dekker, New York 1991; 297
   Google Scholar
• Ownby C. L. Locally acting agents: myotoxins, hemorrhagic toxins and dermonecrotic factors. Handbook of Toxinology, W. T. Shier, D. Mebs, 1990; 601–654
   Google Scholar
• Dennis E. A. Methods Enzymol. Phospholipases 1991; Vol. 197
   Google Scholar
• Ramirez F., Jain M. K. Phospholipase A2 at the bilayer interface. Proteins-Structure. Function and Genetics 1991; 9: 229–239
   Google Scholar
• Takasaki C., Kimura S., Kokubun Y., Tamiya N. Isolation, properties and amino acid sequences of a phospholipase A2 and its homologue without activity from the venom of a sea snake. Laticauda colubrina, from the Solomon Islands. Biochem. J 1988; 253: 869–875
   PubMedGoogle Scholar
• Rowan E. G., Harvey A L., Takasaki C., Tamiya N. Neuromuscular effect of a toxic phospholipase A2 and its nontoxic homologue from the venom of the sea snake. Laticauda colubrina Toxicon 1989; 27: 587–591
   PubMedGoogle Scholar
• Rowan E. G., Harvey A. L., Takasaki C., Tamiya N. Neuromuscular effects of three phospholipases A2 from the venom of the Australian king brown snake Pseudechis australis. Toxicon 1989; 27: 551–560
   Google Scholar
• Chwetzoff S., Tsunasawa S., Sakiyama F., Menez A. Nigexine, a phospholipase A2 from cobra venom with cytotoxic properties not related to esterase activity Purification, amino acid sequence and biological properties. J. Biol. Chem. 1989; 264: 13289–13297
   Google Scholar
• Rowan E. G., Harvey A. L., Menez A. Neuromuscular effects of nigexine, a basic phospholipase A2 from Naja nigricollis venom. Toxicon 1991; 29: 371–374
   PubMedGoogle Scholar
• Bieber A. L., Becker R R., McParland R., Hunt D. F., Shabanowitz J., Yates J. R., III., Martino P. A., Johnson G. R. The complete sequence of the acidic subunit from Mojave toxin determined by Edman degradation and mass spectrometry. Biochim. Biophys. Acta 1990; 1037: 413–421
   PubMed Web of Science ®Google Scholar
• Aird S. D., Kruggel W., Kaiser I. I. Amino acid sequence of the basic subunit of Mojave toxin from the venom of the Mojave rattlesnake (Crotalus s. scutulatus). Toxicon 1990; 28: 669–673
   Google Scholar
• Aird S. D., Yates J. R., III., Martino P. A., Shabanowitz J., Hunt D. F., Kaiser I. I. The amino acid sequence of the acidic subunit β-chain of crotoxin. Biochim. Biophys. Acta 1990; 1040: 217–224
   Google Scholar
• Pearson J. A., Tyler M. I., Retson K. V., Howden M. E. H. Studies on the subunit structure of textilotoxin, a potent presynaptic neurotoxin from the venom of the Australian common brown snake (Pseudonaja textilis). Biochim Biophys. Acta 1991; 1077: 147–150
   PubMed Web of Science ®Google Scholar
• Faure G., Guillaume J. L., Camoin L., Saliou B., Bon C. Multiplicity of acidic subunit isoforms of crotoxin, the phospholipase A2 neurotoxin from Crotalus durissus terrificus venom, results from posttranslational modifications. Biochemistry 1991; 30: 8074–8083
   PubMed Web of Science ®Google Scholar
• Pungercar J., Kordis D., Strukelj B., Liang N. S., Gubensek F. Cloning and nucleotide sequence of a cDNA encoding Ammodytoxin A, the most toxic phosphlipsse A2 from the venom of long-nosed viper (Vipera ammodytes). Toxicon 1991; 29: 269–273
   PubMed Web of Science ®Google Scholar
• Bouchier C., Boulain J. C., Bon C., Menez A. Analysis of cDNAs encoding the two subunits of crotoxin, a phospholipase A2 neurotoxin from rattesnake venom: the acidic non enzymatic subunit derives from a phospholipase A2-like precursor. Biochim Biophys. Acta 1991; 1088: 401–408
   PubMedGoogle Scholar
• Westerlund B., Nordlund P., Uhlin U., Eaker D., Eklund H. The three-dimensional structure of notexin, a presynaptic neurotoxic phospholipase A2 at 2.0 å resolution. FEBS Lett. 1992; 301: 159–164
   Google Scholar
• Dijkstra B. W., Kalk K. H., Hol W. G. J., Drenth J. Structure of bovine pancreatic phospholipase A2 at 1.7 å resolution. J Mol. Biol. 1981; 147: 97–123
   PubMed Web of Science ®Google Scholar
• Dijkstra B. W., Kalk K. H., Hol W. G. J., Orenth J. Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. J. Mol. Biol. 1983; 168: 163–179
   Web of Science ®Google Scholar
• Renetseder R., Brunie S., Dijkstra B. W., Drenth J., Sigler P. B. A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 1985; 260: 11627–11634
   PubMed Web of Science ®Google Scholar
• White S. P., Scott D. L., Otwinowski Z., Gelb M. H., Sigler P. B. Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science 1990; 250: 1560–1563
   PubMed Web of Science ®Google Scholar
• Holland D. R., Clancy L. L., Muchmore S. W., Ryde T. J., Einspahr H. M., Finzel B. C., Heinrikson R. L., Watenpaugh K. D. The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0 å resolution. J. Biol. Chem 1990; 265: 17649–17656
   PubMed Web of Science ®Google Scholar
• Tomoo K., Ohishi H., Doi M., Ishida T., Inoue M., Ikeda K., Hata Y., Semejima Y. Structure of acidic phospholipase A2 for the venom of Agkistrodon halys blomhoffii at 2.8 å resolution. Biochem. Biophys. Res. Commun. 1992; 184: 137–143
   PubMed Web of Science ®Google Scholar
• Chang C. C. Neurotoxins with phospholipase A2 activity in snake venoms. Proc. Natl. Sci. Counc., Rep. China 1985; 9B: 126–142
   Google Scholar
• Harris J. B. Phospholipases in snake venoms and their effects on nerve and muscle. Pharmacol. Ther 1985; 31: 79–102
   PubMed Web of Science ®Google Scholar
• Chang C. C., Lee C. Y. Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action. Arch. Int. Pharmacodyn 1963; 144: 241–257
   PubMedGoogle Scholar
• Hawgood B. J., Smith I. C. H. The importance of phospholipase A2 in the early induction by crotoxin of biphasic changes in end-plate potentials at the frog neuromuscular junction. Toxicon 1989; 27: 272–276
   Google Scholar
• Rufini S., Pedersen J. Z., Desideri A., Luly P. β-Bungarotoxin-mediated liposome fusion: spectroscopic characterization by fluorescence and ESR. Biochemistry 1990; 29: 9644–9651
   Google Scholar
• Rodrigues-Simioni L., Hawgood B. J., Smith I. C. H. Properties of the early phases of crotoxin poisoning at frog neuromuscular junctions. Toxicon 1990; 28: 1479–1489
   PubMed Web of Science ®Google Scholar
• Rowan E G., Pemberton K. E., Harvey A. L. On the blockade of acetylcholine-release at mouse motor-nerve terminals by β-bungarotoxin and crotoxin. Br. J. Pharmacol. 1990; 100: 301–304
   Google Scholar
• Rosenberg P. The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. Natural Toxins, J. B. Harris. Clarendon Press, Oxford 1986; 129–174
   Google Scholar
• Ghassemi A., Dhillon D. S., Rosenberg P. β-bungarotoxin-induced phospholipid hydrolysis in rat brain synaptosomes: Effect of replacement of calcium by strontium. Toxicon 1988; 26: 508–514
   Google Scholar
• Shina R., Yates S. L., Ghassemi A., Rosenberg P., Condrea E. Inhibitory effect of EDTA'PCa2+ on the hydrolysis of synaptosomal phospholipids by phospholipase A2 toxins and enzymes. Biochem. Pharmacol 1990; 40: 2233–2239
   PubMed Web of Science ®Google Scholar
• Nisenbom H E., Perazzo J C., Monserrat A. J., Vidal J. C. Effect of chemical modification with p-bromophenacyl bromide on the enzymatic and lethal properties of phospholipase A2 from Bothrops allernatus (Vibora de la Cruz) venom. Toxicon 1988; 26: 1137–1144
   Google Scholar
• Yang C. C., Chang L. S. Studies on the status of lysine residues in phospholipase A2 from Naja naja alra (Taiwan cobra) snake venom. Biochem J 1989; 262: 855–860
   PubMed Web of Science ®Google Scholar
• Dhillon D. S., Condrea E., Maraganore J. M., Heinrikson R L., Benjamin S., Rosenberg P. Comparison of enzymatic and pharmacological activities of lysine-49 and aspartate-49 phospholipases A2 from agkistrodon piscivorus piscivorus snake venom. Biochem Pharmacol 1987; 36: 1723–1730
   PubMed Web of Science ®Google Scholar
• Rosenberg P., Ghassemi A., Condrea E., Dhillon D., Yang C. H. Do chemical modifications dissociate between the enzymatic and pharmacological activities of β-bungarotoxin and notexin?. Toxicon 1989; 27: 137–159
   PubMed Web of Science ®Google Scholar
• Takasaki C., Sugama A., Yanagita A., Tamiya N., Rowan E. G., Harvey A. L. Effects of chemical modifications of Pa-11. a phospholipase A2 from the venom of Australian king brown snake (Pseudechis australis), on its biological activities. Toxicon 1990; 28: 107–117
   PubMed Web of Science ®Google Scholar
• Petersen M., Penner R., Piereau F. K., Dreyer F. β-Bungarotoxin inhibits a noninactivating potassium current in guinea-pig dorsal root ganglion neurons. Neurosci Lett 1986; 68: 141–145
   PubMed Web of Science ®Google Scholar
• Dreyer F., Penner R. The actions of presynaptic snake toxins on membrane currents of mouse motor nerve terminals. J. Physiol. Lond. 1987; 386: 455–463
   Google Scholar
• Rowan E. G., Harvey A. L. Potassium channel blocking action of β-bungarotoxin and related toxins on mouse and frog motor nerve terminals. Br J. Pharmacol 1988; 94: 839–847
   PubMed Web of Science ®Google Scholar
• Dreyer F. Peptide toxins and potassium channels. Rev. Physiol. Biochem Pharmacol. 1990; 115: 93–136
   PubMed Web of Science ®Google Scholar
• Harvey A. L., Anderson A. J., Marshall D. L., Pemberton K. E., Rowan E. G. Facilitatory neurotoxins and transmitter release. J. Toxicol -Toxin Rev. 1990; 9: 225–242
   Google Scholar
• Strong P. N., Heuser J. E., Kelly R. B. Selective enzyme hydrolysis of nerve terminal phospholipids by β-bungarotoxin: Biochemical and morphological studies. Cellular Neurobiology, Z. Hall, R. B Kelly, C. F. Fox. Alan R. Liss, New York 1977; 227–249
   Google Scholar
• Anderson D. C., Parsons S M. Uncoupling of cholinergic synaptic vesicles by the pre-synaptic toxin β-bungarotoxin. J. Neurochem 1986; 47: 1305–1311
   Google Scholar
• Noremberg K., Parsons S. M. Selectivity and regulation in the phospholipase A2-mediated attack on cholinergic vesicles by β-bungarotoxin. J. Neurochem. 1986; 47: 1312–1317
   Google Scholar
• Shier W. T. The final steps to toxic cell death. J. Toxicol Toxin Rev. 1985; 4: 191–249
   Google Scholar
• Fletcher J. E., Rapuano B. E., Condrea E., Yang C., Ryan M., Rosenberg P. Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom - II Pharmacological properties in relationship to enzymatic activity. Biochem. Pharmacol. 1980; 29: 1565–74
   PubMedGoogle Scholar
• Condrea E., Fletcher J. E., Rapuano B. E., Yang C. C., Rosenberg P. Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2. Toxicon 1981; 19: 705–720
   PubMed Web of Science ®Google Scholar
• Condrea E., Fletcher J. E., Rapuano B. E., Yang C. C., Rosenberg P. Effect of modificatin of one histidine residue on the enzymatic and pharmacological properties of a toxic phospholipase A2 from Naja nigricollis snake venom and less toxic phospholipases A2 from Hemachatus haemacatusand Naja naja atra snake venoms. Toxicon 1981; 19: 61–71
   PubMed Web of Science ®Google Scholar
• Nicholls D., Snelling R., Dolly O. Bioenergetic actions of β-bungarotoxin, dendrotoxin and bee-venom phospholipase A2 on guinea-pig synaptosomes. Biochem J 1985; 229: 653–662
   Google Scholar
• Rugolo P., Dolly J. O., Nicholls D. G. The mechanisms of action of β-bungarotoxin at the pre-synaptic plasma membrane. Biochem. J. 1986; 233: 519–523
   PubMed Web of Science ®Google Scholar
• Yates S. L., Burns M., Condrea E., Ghassemi A., Shina R., Rosenberg P. Phospholipid hydrolysis and loss of membrane integrity following treatment of rat brain synaptosomes with β-bungarotoxin. notexin. and Naja naja atra and Naja nigricollis phospholipase. Toxicon 1990; 29: 939–951
   Google Scholar
• Yates S. L., Rosenberg P. Comparative effects of phospholipase A2 neurotoxins and enzymes on membrane potential and Na+/K+ ATPase activity of rat brain synaptosomes. Toxicol. Appl. Pharmacol. 1991; 109: 207–218
   Google Scholar
• Fletcher J. E., Middlebrook J. L. Effects of β-bungarotoxin and Naja naja atra snake venom phospholipase A2 on acetylcholine release and choline uptake in synaptosomes. Toxicon 1986; 24: 91–99
   Google Scholar
• Jiang M., Haggblad J., Heilbronn E., Rydqvist B., Eaker D. Some biochemical characteristics and cell membrane actions of a toxic phospholipase A2 isolated from the venom of the pit viper Agkistrodon halys (Pallas). Toxicon 1987; 25: 785–792
   Google Scholar
• Mollier P., Brochier G., Morot Gaudry-Talarmain Y. The action of notexin from tiger snake venom (Notochis s scutatus) on acetylcholine release and compartmentation in synaptosomes from electric organ of. Torpedo marmorata Toxicon 1990; 28: 267–276
   Google Scholar
• Delot E, Bon C. Differential effects of presynaptic phospholipase A2 neurotoxins on Torpedo synaptosomes. J. Neurochem. 1992; 58: 311–319
   PubMed Web of Science ®Google Scholar
• Wernicke J. F., Vanker A. D., Howard B. D. The mechanism of action of β-bungarotoxin. J. Neurochem 1975; 25: 483–496
   PubMed Web of Science ®Google Scholar
• Martinez C., Perez-Martos A., Lopez-Perez M. J. Quantitation of the β-bngarotoxin-induced release of lactate dehydrogenase from cerebrocortical synaptosomes. Neurochem Res. 1989; 14: 865–869
   Google Scholar
• Garcia-Garayo J. J., Cebrian J. A., Muino M. T., Lopez- Perez M. J. Phase partition of β-bungarotoxin-treated cerebrocortical synaptosomes quantitation of the toxin- vulnerable population. Res, Common. Chem. Pathol Pharmac. 1990; 68: 55–63
   Google Scholar
• Smith C. C.T., Bradford H F, Thompson E J., MacDermot J. Actions of β-bungarotoxin on amino acid transmitter release. J. Neorochem. 1980; 34: 487–494
   Google Scholar
• Benishin C. G. Potassium channel blockade by the B subunit of β-bungarotoxin. J. Pharmacol Exp. Ther 1990; 38: 164–169
   Google Scholar
• Ueno E., Rosenberg P. Inhibition of phosphorylation of rat synaptosomal proteins by snake venom phospholipase A2 neurotoxins (β-bungarotoxin, notexin) and enzymes (Naja naja atra. Naja nigricollis). Toxicon 1990; 28: 1423–1437
   Google Scholar
• Storella R J., Schouchoff A L., Fujii M, Hill J., Fletcher J. E., Jiang M S., Smith L A. Preliminary evidence for a postsynaptic action of β-bungarotoxin in mammalian skeletal muscle. Toxicon 1992; 30: 349–354
   Google Scholar
• Chang C. C., Chen T F., Lee C. Y. Studies of the pre-synaptic effect of β-bungarotoxin on neuromuscular transmission. J. Pharmacol Exp. Ther 1973; 184: 339–345
   PubMed Web of Science ®Google Scholar
• Strong P. N., Goerke J., Oberg S G., Kelly R. B. β- Bungarotoxin a presynaptic toxin with enzymatic activity. Proc. Natl Acad Sci USA 1976; 73: 178–182
   PubMed Web of Science ®Google Scholar
• Abe T., Limbrick A. R., Miledi R. Acute muscle denervation induced by β-bungarotoxin. Proc. R. Soc, Lond. 1976; 194: 545–553
   PubMedGoogle Scholar
• Howard B. D., Truog R. Relationship between the neurotoxicity and phospholipase A activity of β-bungarotoxin. Biochemistry 1977; 16: 122–125
   Google Scholar
• Chang O C. C., Lee J. D. Crotoxin. the neurotoxin of South American rattlesnake venoms, is a pre-synaptic toxin acting like β-bungarotoxin. Naunyn Schmiedebergs Arch Pharmacol 1977; 296: 159–168
   PubMed Web of Science ®Google Scholar
• Ng R. H., Howard B. D. Mitochondria and sarcoplasmic reticulum as model targets for neurotoxic and myotoxic phospholipases A2. Proc Natl. Acad Sci. USA 1980; 77: 1346–1350
   PubMed Web of Science ®Google Scholar
• Caratsch C. G., Maranda B., Miledi R., Strong P. N. A further study of the phospholipase-independent action of β-bungarotoxin at frog endplates. J Physiol. Lond. 1981; 319: 179–191
   Google Scholar
• Marlas G., Bon C. Relationship between the pharmacological action of crotoxin and its phospholipase activity. Eur. J. Biochem. 1982; 125: 157–165
   PubMedGoogle Scholar
• Trivedi S., Kaiser I. I., Tanaka M., Simpson L. L. Pharmacological experiments on the interaction between crotoxin and the mammatian neuromuscular junction. J. Pharmacol Exp. Ther. 1989; 251: 490–496
   Google Scholar
• Kini R. M., Evans H. J. A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 1989; 27: 613–635
   PubMed Web of Science ®Google Scholar
• Freedman J. E., Snyder S. H. Vipoxina protein from Russell's viper venom with high affinity for biogenic amine receptors. J. Biol. Chem 1981; 256: 13172–13179
   PubMed Web of Science ®Google Scholar
• Napias C., Heilbronn E. Phospholipase A2 activity and substrate specificity of snake venom pre-synaptic toxins. Biochemistry 1980; 19: 1146–1151
   Google Scholar
• Lunney J., Ashwell G. The effect of phospholipase on the binding of asialoglycoproteins by rat liver plasma membranes. Biochim. Biophys. Acta 1974; 367: 304–315
   Google Scholar
• Pasternak G. W., Snyder S. H. Opiate receptor binding: Enzymatic treatments that discriminate between agonist and antagonist interactions. Molec Pharmac. 1975; 11: 478–484
   Web of Science ®Google Scholar
• Giambalvo C. T., Rosenberg P. The effect of phospholipases and proteases on the binding of γ-aminobutyric acid to junctional complexes of rat cerebellum. Biochim. Biophys. Acta 1976; 436: 741–756
   Google Scholar
• Denburg J. L. Interaction of phospholipase A with an axon plasma membrane preparation. Life Sci. 1976; 18: 751–758
   Google Scholar
• Lin H. K., Simon E. J. Phospholipase A inhibition of opiate receptor binding can be reversed by albumin. Nature 1978; 271: 383–384
   Google Scholar
• Hanley M. R. Crotoxin effects on Torpedo californica cholinergic excitable vesicles and the role of its phospholipase A activity. Biochem. Biophys. Res. Commun. 1978; 82: 392–401
   Google Scholar
• Okamoto H. Binding of scorpion toxin to sodium channels in vitro and its modification by p-bungarotoxin. J. Physiol. 1980; 299: 507–520
   Google Scholar
• Goldman M. E., Pisano J. J. Inhibition of [3H] nitrendipine binding by phospholipase A2. Life Sci. 1985; 37: 1301–1308
   Google Scholar
• Kasckow J. W., Abood L. G., Hoss W., Herndon R. M. Mechanism of Phospholipase A2 - induced conduction block in bullfrog sciatic nerve. II Biochemistry. Brain Res. 1986; 373: 392–398
   Google Scholar
• Havoundjian H., Cohen R. M., Paul S. M., Skolnick P. Differential sensitivity of “central” and “peripheral” type benzodiazepine receptors to phospholipase A2. J. Neurochem. 1986; 46: 804–811
   PubMed Web of Science ®Google Scholar
• Rehm H. Molecular aspects of neuronal voltage-dependent K+ channels. Eur. J. Biochem. 1991; 202: 701–713
   PubMedGoogle Scholar
• Dolly J. O. Potassium channels - what can the protein chemistry contribute. Trends Neurosci. 1988; 11: 186–188
   Google Scholar
• Moczydlowski E., Lucchesi K., Ravindran A. An emerging pharmacology of peptide toxins targeted against potassium channels. J. Membr. Biol. 1988; 105: 95–111
   PubMed Web of Science ®Google Scholar
• Strong P. N. Potassium channel toxins. Pharmac Ther. 1990; 46: 137–162
   PubMed Web of Science ®Google Scholar
• Rehm H., Tempel B. L. Voltage-gated K+ channels of the mammalian brain. FASEB J. 1991; 5: 164–170
   PubMedGoogle Scholar
• Rehm H., Betz H. Binding of β-bungarotoxin to synaptic membrane fractions of chick brain. J. Biol Chem. 1982; 257: 10015–10022
   PubMed Web of Science ®Google Scholar
• Othman I. B., Spokes J. W., Dolly J. O. Preparation of neurotoxic 3H-β-bungarotoxin: Demonstration of a saturable binding to brain synapses and its inhibition by toxin I. Eur J. Bichem 1982; 128: 267–276
   PubMedGoogle Scholar
• Schmidt R. R., Betz H., Rehm H. Inhibition of β-bungarotoxin binding to brain membranes by mast cell degranulating peptide. toxin I. and ethylene glycol bis(β- aminoethyl ether)-N.N.N.N-tetracetic acid. Biochemistry 1988; 27: 963–967
   PubMed Web of Science ®Google Scholar
• Rehm H., Betz H. Solubilization and characterization of the β-bungarotoxin-binding protein of chick brain membranes. J. Biol. Chem. 1984; 259: 6865–6869
   PubMed Web of Science ®Google Scholar
• Tomlinson G. Inhibition of radioligand binding to receptors a competitive business. Trends pharmacol. Sci. 1988; 9: 159–162
   PubMedGoogle Scholar
• Rehm H., Becker C. M. Interpreting non-competitive inhibition. Trends Pharmacol Sci 1988; 9: 316–317
   Google Scholar
• Harvey A. L., Karlsson E. Protease inhibitor homologues from mamba venoms. Facilitation of acetylcholine release and interaction with prejunctional blocking toxins. Br. J. Pharmacol 1982; 77: 153–161
   PubMed Web of Science ®Google Scholar
• Rudy B. Diversity and ubiquity of K+ channels. Neurosciences 1988; 25: 729–749
   PubMed Web of Science ®Google Scholar
• Cook N. S. The pharmacology of potassium channels and their theraputic potential. Trends Pharmacol Sci 1988; 9: 21–28
   PubMed Web of Science ®Google Scholar
• Castle N. A., Haylett D. G., Jenkinson D. H. Toxins in the characterization of potassium channels. Trends Neurosci. 1989; 12: 59–65
   PubMed Web of Science ®Google Scholar
• Kolb H.-A. Potassium channels in excitable and non-excitable cells. Rev. Physiol. Biochem. Pharmacol. 1990; 115: 51–91
   Google Scholar
• Lucchesi K., Moczydlowski E. Subconductance behavior in a maxi Ca2+-activated K+-channel induced by dendrotoxin I. Neuron 1990; 4: 141–148
   PubMedGoogle Scholar
• Black A R., Dolly J. O. Two acceptor sub-types for dendrotoxin in chick synaptic plasma membranes distinguishable by β-bungarotoxin. Eur. J. Biochem 1986; 156: 609–617
   Google Scholar
• Black A R., Donegan C M., Denny B J., Dolly J. O. Solubilization and physical characterization of acceptors for dendrotoxin and β-bungarotoxin from synaptic membranes of rat brain. Biochemistry 1988; 27: 6814–6820
   PubMed Web of Science ®Google Scholar
• Dolly J. O., Stansfeld C. E., Breeze A., Pelchen-Matthews A., Marsh S. J., Brown D A. Neuronal acceptor subtypes for dendrotoxin and their relation to K+ channels. Neurotoxins and Their Pharmacological Implications, P. Jenner. Raven Press, New York 1987; 81–86
   Google Scholar
• Breeze A. L., Dolly J. O. Interactions between discrete neuronal membrane binding sites for the putative K+ -channel ligands β-bungarotoxin. dendrotoxin and mast-cell-degranulating peptide. Eur. J Biochem 1989; 178: 771–778
   PubMedGoogle Scholar
• Stansfeld C. E., Marsh S. J., Parcej D. N., Dolly J. O., Brown D. A. Mast cell degranulation peptide and dendrotoxin selectively inhibit a fast-activating potassium current and bind to common neuronal proteins. Neuroscience 1987; 23: 893–902
   Google Scholar
• Black A. R., Breeze A. L., Othman I. B., Dolly J. O. Involvement of neuronal acceptors for dendrotoxin in its convulsive action in rat brain. Biochem J 1986; 237: 397–404
   PubMedGoogle Scholar
• Harvey A. L., Marshall D. L., De-Allie F. A., Strong P. N. Interactions between dendrotoxin. a blocker of voltage-dependent potassium channels. And charybdotoxin. a blocker of calcium-activated potassium channels. at binding sites on neuronal membranes. Biochem. Biophys Res. Commun. 1989; 163: 394–397
   PubMed Web of Science ®Google Scholar
• Schweitz H., Bidard J.-N., Maes P., Lazdunski M. Charybdotoxin is a new member of the K+ channel toxin family that includes dendrotoxin I and mast celldegranulating peptide. Biochemistry 1989; 28: 9708–9714
   PubMed Web of Science ®Google Scholar
• Vazquez J., Feigenbaum P., King V. F., Kaczorowski G. F., Garcia M. L. Characterization of high affinity binding sites for charybdotoxin in synaptic plasma membranes from rat brain. J. Biol. Chem. 1990; 265: 15564–15571
   Google Scholar
• Oliva C., Folander K., Smith J. S. Charybdotoxin is not a high affinity blocker of shaker K+ channels expressed in Xenopus oocytes. Biophys. J. 1991; 59: 450a
   Google Scholar
• Taylor J. W., Bidard J. N., Lazdunski M. The characterization of high-affinity binding sites in rat brain for the mast cell-degranulating peptide from bee venom using the purified monoiodinated peptide. J. Biol, Chem 1984; 259: 13957–13967
   PubMed Web of Science ®Google Scholar
• Bidard J.-N., Gandolfo G., Mourre C., Gottesmann C., Lazdunski M. The brain response to the bee venom peptide MCD. Activation and desensitization of ahippocampal target. Brain Res. 1987; 418: 235–244
   Google Scholar
• Bidard J-N, Mourre C., Lazdunski M. Two potent central convulsant peptides. a bee venom toxin. the MCD peptide. and a snake venom toxin, dendrotoxin I. known to block K+-channels. have interacting receptor sites. Biochem. Biophys. Res. Commun. 1987; 143: 383–389
   Google Scholar
• Mourre C., Bidard J. N., Lazdunski M. High-affinity receptors for the bee venom MCD peptide. Quantitative autoradiographic localization at different stages of brain development and relationship with MCD neurotoxicity. Brain Res. 1988; 446: 106–112
   Google Scholar
• Deutsch C., Price M., Lee S., King V F., Garcia M. L. Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. J. Biol. Chem. 1991; 266: 3668–3674
   PubMed Web of Science ®Google Scholar
• Vazquez J., Feigenbaum P., Katz G., King V. F., Reuben J. P., Roy-Contancin L., Slaughter R. S., Kaczorowski G. J., Garcia M. L. Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle. J. Biol. Chem. 1989; 264: 20902–20909
   Google Scholar
• Tzeng M C., Hseu M. J., Yang J. H., Guillory R. J. Specific binding of three neurotoxins with phospholipase A2 activity to the synaptosomal membrane preparations from the guinea pig brain. J. Protein Chem 1986; 5: 221–228
   Google Scholar
• Hirokawa N. Characterization of various nervous tissues of the chick embryos through responses to chronic application and immunocytochemistry of β-bungarotoxin. J. Comp. Neur. 1978; 180: 449–466
   Google Scholar
• Hirokawa N. A study of the synaptogenesis in the cerebellar cortex through chronic treatment and immunocytochemistry of β-bungarotoxin. J Comp Neur 1979; 185: 107–120
   Google Scholar
• Othamn I. B, Wilkin G. P., Dolly J. O. Synaptic binding sites in brain for [3H]β-bungarotoxin - a specific probe that perturbs transmitter release. Neurochem. Intl. 1983; 5: 487–496
   Google Scholar
• Dolly J. O., Halliwell J. V., Black J. D., Williams R. S., Pelchen-Matthews A., Breeze A. L., Mehraban F., Othman I. B, Black A. R. Botulinum neurotoxin and dendrotoxin as probes for studies on transmitter release. J. Physiol. Paris 1984; 79: 280–303
   PubMedGoogle Scholar
• Halliwell J. V., Othman I. B., Pelchen-Matthews A., Dolly J. O. Central action of dendrotoxin Selective reduction of a transient K+ conductance in hippocampus and binding to localized acceptors. Proc Natl Acad Sci USA 1986; 83: 493–497
   PubMedGoogle Scholar
• Pelchen-Matthews A., Dolly J. O. Distribution of acceptors for β-bungarotoxin in the central nervous system of the rat. Brain Res. 1988; 441: 127–138
   Google Scholar
• Pelchen-Matthews A., Dolly J. O. Distribution in the rat central nervous system of acceptor sub-types for dendrotoxin a K+ channel probe. Neuroscience 1989; 29: 347–361
   Google Scholar
• Bidard J-N., Mourre C., Gandolfo G., Schweitz H., Widmann C., Gottesmann C., Lazdunski M. Analogies and differences in the mode of action and properties of binding sites (localization and mutual interactions) of two K+-channel toxins. MCD peptide and dendrotoxin I. Brain Res 1989; 495: 45–57
   PubMed Web of Science ®Google Scholar
• Katoh-Semba R., Semba R., Kashiwamata S. Age-dependent and selective binding of β-bungarotoxin to GABAergic neurons in the rat cerebellum. Neurosci Lett 1987; 76: 32–36
   Google Scholar
• Rehm H., Schafer T., Betz H. β-Bungarotoxin-induced cell death of neurons in chick retina. Brain Res 1982; 250: 309–319
   PubMed Web of Science ®Google Scholar
• Esquerda J E., Solsona C. W., Marsal J. Binding of β-bungarotoxin to Torpedo electric organ synaptosomes, A high resolution autoradiographic study. Neuroscience 1982; 7: 751–758
   Google Scholar
• Gandolfo G., Gottesmann C., Bidard J. N., Lazdunski M. Subtypes of K+ channels differentiated by the effect of K+ -channel openers upon K+ -channel blocker-induced seizures. Brain Res 1989; 495: 189–192
   Google Scholar
• Gandolfo G., Gottesmann C., Bidard J-N, Lazdunski M. K. channel openers prevent epilepsy induced by the bee venom peptide MCD. Eur., J. Pbarmacol. 1989; 159: 329–330
   Google Scholar
• Heurteaux C., Lazdunski M. MCD peptide and dendrotoxin I activate C-fos and C-jun expression by acting on two different types of K+ channel opener lemakalin. Brain Res 1991; 554: 22–29
   Google Scholar
• Benishin C. G., Sorensen R. G., Brown W. E., Krueger B. K., Blaustein M. P. Four polypeptide components of green mamba venom selectively block certain potassium channels in rat brain synaptosomes. Mol. Pharmacol 1988; 34: 152–159
   PubMed Web of Science ®Google Scholar
• Muniz Z. M., Diniz C. R., Dolly J. O. Characterisation of binding sites for δ-dendrotoxin in guinea-pig synaptosomes: relationship to acceptors for the K+-channel probe αdendrotoxin. J. Neurochem. 1990; 54: 343–346
   Google Scholar
• Muniz Z. M., Tibbs G. R., Maschot P., Bougis P., Kicholls D. G., Dolly J. O. Homologues of a K+ -channel blocker δ-dendrotoxin: characterization of synaptosomal binding sites and their coupling to elevation of cytosolic free calcium concentration. Neurochem. Int. 1990; 16: 105–112
   Google Scholar
• Awan K. A., Dolly J. O.K. channel subtypes in rat btain Vcharacteristic locations revealed using β-bungarotoxin. αdendrotoxin and δ-dendrotoxin. Neuroscience 1991; 40: 29–39
   Google Scholar
• Brau M. E., Dreyer F., Jonas P., Repp H., Vogel W. A. K. channel in Xenopus nerve fibers selectively blocked by bee and snake toxins: binding and voltage-clamp experiments. J, Physiol. (London) 1990; 420: 365–385
   Google Scholar
• Rehm H., Betz H. Identification by cross-linking of a β-bungarotoxin binding polypeptide in chick brain membranes. EMBO J. 1983; 2: 119–122
   Google Scholar
• Schmidt R. R., Betz H. Cross-linking of β-bungarotoxin to chick brain membranes. Identification of subunits of a putative voltage-gated K+ -channel. Biochemistry 1989; 28: 8346–8350
   PubMed Web of Science ®Google Scholar
• Mehraban F., Breeze A. L., Dolly J. O. Identification by cross-linking of a neuronal acceptor protein for dendrotoxin. a convulsant polypeptide. FEBS Lett 1984; 174: 116–122
   PubMed Web of Science ®Google Scholar
• Rehm H., Bidard J. N., Schweitz H., Lazdunski M. The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I. asnake toxin active on K+ channels. Bichemistry 1988; 27: 1827–1832
   PubMed Web of Science ®Google Scholar
• Garcia-Calvo M., Vazquez J., Smith M., Kaczorowski G. J., Garcia M. L. Characterization of the solubilized charybdotoxin receptor from bovine aortic smooth muscle. Biochemistry 1991; 30: 11157–11164
   Google Scholar
• Parcej D. N., Dolly J. O. Dendrotoxin acceptor from bovine synaptic plasma membranes. Binding properties, purification and subunit composition of a putative constituent of certain voltage-activated K+ channels. Biochem. J 1989; 257: 899–903
   Google Scholar
• Schmidt R. R., Betz M. The β-bungarotoxin-binding protein from chick brain. binding sites for different neuronal K+-channel ligands co-fractionate upon partial purification. FEBS Lett 1988; 240: 65–70
   Google Scholar
• Rehm H., Lazdunski M. Existence of different populations of dendrotoxin I binding protein associated with neuronal K+ channels. Biochem Biophys. Res. Commun 1988; 153: 231–240
   Google Scholar
• Rehm H., Lazdunski M. Purification and subunit structure of a putative K+ -channel protein identified by its binding properties for dendrotoxin I. Proc. Natl. Acad Sci. USA 1988; 85: 4919–4923
   PubMedGoogle Scholar
• Scott V. E. S., Parcei D. N., Keen J. N., Findlay J. B. C., Dolly J. O. αDendrotoxin acceptor from bovine brain is a K+ channel protein. Evidence from the N-terminal sequence of its larger subunit. J. Biol. Chem. 1990; 265: 20094–20097
   Google Scholar
• Rehm H. Enzymatic deglycosylation of the dendrotoxin-binding protein. FEBS Lett 1989; 247: 28–30
   Google Scholar
• Rehm H., Newitt R. A., Tempel B. L. Immunological evidence for a relationship between the dendrotoxin-binding protein and the mammalian homologue of the Drosophila Shaker K+ channel. FEBS Lett 1989; 249: 224–228
   Google Scholar
• Rehm H., Pelzer S., Cochet C., Chambaz E., Tempel B. L., Pelzer Trautwein W.D., Lazdunski M. Dendrotoxin- binding brain membrane protein displays a K+ -channel activity that is stimulated by both CAMP-dependent and endogenous phosphorylations. Biochemistry 1989; 28: 6455–6460
   PubMed Web of Science ®Google Scholar
• Jan L. Y., Jan Y. N. How might the diversity of potassium channels be generated?. Trends Neorosci 1990; 13: 415–419
   PubMedGoogle Scholar
• Stuhmer W. Structure-function studies of voltage-gated ion channels. Ann. Rev. Biophys. Chem. 1991; 20: 65–78
   Google Scholar
• Perney T. M., Kaczmarek L. K. The Molecular biology of K+ channels. Curr. Opin. Cell Biol. 1991; 3: 663–670
   Google Scholar
• Mackinnon R. Using mutagenesis to study potassium channel mechanisms. J. Bioenerg. Biomembr. 1991; 23: 647–663
   Google Scholar
• Miller C. 1990: Annus mirabilis of potassium channels. Science 1991; 252: 1092–1096
   PubMedGoogle Scholar
• Jan L. Y., Jan Y. N. Structural elements involved in specific K+ channel functions. Ann. Rev. Physiol. 1992; 54: 537–555
   PubMedGoogle Scholar
• Salkoff L., Baker K., Butler A., Covarrubias M., Pak M. D., Wei A. An essential 'set' of K+ channels conserved in flies, mice and humans. Trends Neorosic. 1992; 15: 161–166
   PubMed Web of Science ®Google Scholar
• Saliou F., Radvanyi B., Bon C., Strong P. N. The interaction between the presynaptic phospholipase neurotoxins β-bungarotoxin and crotoxin and mixed detergent - phosphatidylcho-line micelles A comparison with nonneurotoxic snake venom phospholipases A2. J. Biol. Chem. 1987; 262: 8966–8974
   Google Scholar
• Jain M., Egmond M. R., Verheij H., Apitz-Castro R., Dijkman R., De Haas G. H. Interaction of Phospholipase A2 and phospholipid bilayers. Biochim Biophys. Acta. 1982; 688: 341–348
   PubMedGoogle Scholar
• Jain M. K., Rogers J., Jahagirdar D. V., Marecek J. F., Ramirez F. Kinetics of interfacial catalysis by phospholipase A2 in intravesicie scooting mode, and heterofusion of anionic and zwitterionic vesicles. Biochim Biophys Acta 1986; 860: 435–447
   Google Scholar
• Habermann E., Beithaupt H. The crotoxin complex is an example of biochemical and pharmacological complementation. Toxicon 1978; 16: 19–30
   PubMed Web of Science ®Google Scholar
• Fraenkel-Conrat H. Snake venom neurotoxins related to phospholipase A2. J. Toxicol. Toxin Rev. 1982; 1: 205–221
   Web of Science ®Google Scholar
• Hendon R. A., Bieber A. L. Presynaptic toxins from rattlesnake venoms. Rattlesnake venoms: Their action and treatment, A. T. Tu. Marcel Dekker, New York 1982; 211
   Google Scholar
• Hawgood B. J. Physiological and pharmacological effects of rattlesnake venoms. Rattlesnake venoms. Their action and treatment, A. T. Tu. Marcel Dekker, New York 1982; 121
   Google Scholar
• Bon C., Bouchier C., Choumet V., Faure G., Jiang M.-S., Lambezat M.-P., Radvanyi F., Saliou B. Crotoxin. half- century of investigations of a phospholipase A2 neurotoxin Acta physiol, pharmacol. Latino-Americano 1989; 39: 439–448
   Google Scholar
• Bieber A. L., Mills J. P., Jr., Ziolkowski C., Harris J. Rattlesnake neurotoxins biochemical and biological aspects. J. Toxicol-Toxin Rev. 1990; 9: 285–306
   Web of Science ®Google Scholar
• Jeng T. W., Hendon R. A., Fraenkel-Conrat H. Search for relationship among the hemolytic. phospholipolytic and neurotoxic activities of snake venom. Proc. Natl. Acad. Sci USA 1978; 75: 600–604
   PubMed Web of Science ®Google Scholar
• Bon C., Changeux J. P., Jeng T. W., Fraenkel-Conrat H. Post-synaptic effects of crotoxin and of its isolated subunits. Eur. J. Biochem. 1979; 99: 471–481
   Google Scholar
• Chang C. C., Su M. J. A study on the interaction of crotapotin with crotoxin phospholipase A2. notexin and other presynaptic neurotoxins. Br. J. Pharmacol. 1981; 73: 495–503
   Google Scholar
• Degn L. L., Seebart C. S., Kaiser I. I. Specific binding of crotoxin to brain synaptosomes and synaptosomal membranes. Toxicon 1991; 29: 973–988
   PubMed Web of Science ®Google Scholar
• Canziani G., Seki C., vidal J. C. The mechanism of inhibition of phospholipase activity of crotoxin B by crotoxin A. Toxicon 1983; 21: 663–674
   Google Scholar
• Radvanyi F., Saliou B., Lembezat M. P., Bon C. Negatively charged phospholipids, a possible target for crotoxin, a presynaptic phospholipase A2 neurotoxin. J. Neurochem. 1989; 53: 1252–1260
   PubMed Web of Science ®Google Scholar
• Lambeau G., Schmid-Alliana A., Lazdunski M., Barhanin J. Identification and purification of a very high affinity binding protein for toxic phospholipase A2 in skeletal muscle. J. Biol. Chem. 1990; 265: 9526–9532
   Google Scholar
• Chang C. C., Su M. J. Mutual potentiation at nerve terminals between toxins from snake venoms which contain phospholipase A2 activity β-bungarotoxin, crotoxin, taipoxin. Toxicon 1980; 18: 641–648
   PubMed Web of Science ®Google Scholar
• Hseu M. J., Guillory R. J., Tzeng M. C. Identification of a crotoxin-binding protein in membranes from guinea pig brain by photoaffinity labeling. J. Bioenerg Biomembr. 1990; 22: 39–50
   PubMed Web of Science ®Google Scholar
• Yen C. H., Tzeng M. C. Identification of a new binding protein for crotoxin and other neurotoxic phospholipase A2 on brain synaptic membranes. Biochemistry 1991; 30: 11473–11477
   Google Scholar
• Fohlman J., Eaker D., Karlsson E., Thesleff S. Taipoxinan extremely potent pre-synaptic neurotoxin from the venom of Australian snake taipan (Oxyuranus scutellatus scutellatus). Isolation, characterization, quaternary structure and pharmacological properties. Eur. J. Biochem. 1976; 68: 457–469
   PubMedGoogle Scholar
• Hendon R. A., Tu A. T. The role of the crotoxin subunits in tropical rattlesnake neurotoxic action. Biochim. Biophys. Acta 1979; 578: 243–252
   PubMedGoogle Scholar
• Hseu M. J., Yang J. H., Guillory R. J, Tzeng M. C. Characteristics of the binding of crotoxin and Mojave toxin to synaptosomal membranes from guinea pig brain. 13th International Congress of Biochemistry, Amsterdam, 1985, 143
   Google Scholar
• Batzri-Izraeli R., Bdolah A. Isolation and characterization of the main toxic fraction from the venom of the false horned viper (Pseodocerasres fieldi). Toxicon 1982; 20: 867–875
   Google Scholar
• Bdolah A., Kinamon S., Batzri-Izraeli R. The neurotoxic complex from the venom of Pseudocerastes fieldi Contribution of the nontoxic subunit. Biochem Int. 1985; 11: 627–636
   Google Scholar
• Tsai M. C, Lee C Y., Bdolah A. Mode of neuromuscular blocking action of a toxic phsspholipase A2 from Pseudocerastes fieldi (Field's horned viper) snake venom. Toxicon 1983; 21: 527–534
   PubMedGoogle Scholar
• Shabo-Shina R., Bdolah A. Interactions of the neurotoxic complex from the venom of the false horned viper (pseudocerastes fieldi) with rat striatal synaptosomes. Toxicon 1987; 25: 253–266
   Google Scholar
• Harris J, Power T J., Bieber A. L., Watts A. An Electron-spin-resonance spin-label study of the interaction of purified Mojave toxin with synaptosomal membranes from rat brain. Eur J Biochem. 1983; 131: 559–565
   PubMedGoogle Scholar
• Chambers J P., Wayner M J., Dungan J., Rael E D., Valdes J. The effects of purified Mojave toxin on rat synaptic membrane (Ca+2 Mg+2)-ATPase and the dihydropyridine receptor. Brain Res Bull 1986; 16: 639–643
   PubMed Web of Science ®Google Scholar
• Valdes J. J., Thompson R. G., Wolff V. L., Menking D. E., Rael E. D., Chambers J. P. Inhibition of calcium channel dihydropyridine receptor binding by purified Mojave toxin. Neurotoxicol Teratol 1989; 11: 129–133
   PubMed Web of Science ®Google Scholar
• Dowdall M. J., Fohlman J. P., Watts A. Presynaptic action of snake venom neurotoxins on cholinergic systems. Adv. Cytopharmacol. 1979; 3: 63–76
   PubMedGoogle Scholar
• Cull-Candy S. G., Fohlman J., Gustavsson D., Lullmann-Rauch R., Thesleff S. The effects of taipoxin and notexin on the function and fine structure of the murine neuromuscular junction. Neuroscience 1976; 1: 175–180
   PubMed Web of Science ®Google Scholar
• Chang C. C., Lee J. D., Eaker Fohlman D. The pre- synaptic neuromuscular blocking actions of taipoxin A comparison with β-bungarotoxin and crotoxin. Toxicon 1977a; 15: 571–576
   PubMed Web of Science ®Google Scholar
• Tzeng M. C., Hseu M. J., Yen C. H. Taipoxin-binding protein on synaptic membranes: Identification by affinity labeling. Biochem. Biophys. Res. Commun. 1989; 165: 689–694
   Google Scholar
• Backstrom I. T., Ross S. B., Marcusson J. O. [3H]desipramine binding to rat brain tissue; binding to both noradrenaline uptake sites and sites not related to noradrenaline neurons. J. Neurochem 1989; 32: 1099–1106
   Google Scholar
• Dowdall M. J., Fohlman J. P., Eaker D. Inhibition of high affinity choline transport in peripheral cholinergic endings by pre-synaptic snake venom neurotoxins. Nature 1977; 269: 700–702
   Google Scholar
• Fohlman J., Eaker D., Dowdall M. J., Lullmann-Rauch R., Sjodin T., Leander S. Chemical modification of taipoxin and the consequences for phospholipase activity, pathophysiology, and inhibition of high-affinity choline uptake. Eur. J. Biochem. 1979; 94: 531–540
   PubMedGoogle Scholar
• Sun A. Y. The effect of phospholipases on the active uptake of norepinephrine by synaptosomes isolated from the cerebral cortex of guinea pig. J. Neurochem 1974; 22: 551–556
   Google Scholar
• Rotman A. The effect of phospholipase C. phospholipase A2 and neuraminidase on the uptake of [3H]norepinephrine and [3H]serotonin by rat brain synaptosomes. J. Neurochem 1977; 28: 1369–1372
   Google Scholar
• Helmke S., Howard B. D. Mechanism of inhibition of calcium uptake into sarcoplasmic reticulum by notexin. a neurotoxic and myotoxic polypeptide. Memb. Biochem. 1986; 6: 239–253
   Web of Science ®Google Scholar
• Lambeau G., Barhanin J., Schweitz H., Oar J., Lazdunski M. Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J. Biol. Chem 1989; 264: 11503–11510
   PubMedGoogle Scholar
• Lambeau G., Barhanin J., Lazdunski M. Identification of different receptor types for toxic phospholipases A2 in rabbit skeletal muscle. FEBS Lett 1991; 293: 29–33
   Google Scholar
• Lambeau G., Ladunski M., Barhanin J. Properties of receptors for neurotoxic phospholipases A2 in different tissues. Neurochem. Res. 1991; 16: 651–658
   PubMedGoogle Scholar
• Arita H., Hanasaki K., Nakano T., Oka S., Teraoka H., Matsumoto K. Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J. Biol Chem 1991; 266: 19139–19141
   PubMed Web of Science ®Google Scholar
• Hanasaki K., Arita H. Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. J. Biol. Chem. 1992; 267: 6414–6420
   Google Scholar
• Rapuano B. E., Yang C. C., Rosenberg P. The relationship between high-affinity noncatalytic binding of snake venom phospholipases A2 to brain synaptic plasma membranes and their central lethal potencies. Biochim. Biophys. Acra 1986; 856: 457–470
   Google Scholar
• Ouyang C., Teng C.-M., Chen Y. C., Lin S. C. Purification and characterization of the anticoagulant principle of Trimeresurus mucrosquamatus venom. Biochim. Biophys. Acta 1978; 541: 394–407
   PubMedGoogle Scholar
• Bevan P., Hiestand P. β-RTX.a receptor-active protein from Russell's viper (Vipera russelli russelli) venom. J. Biol. Chem. 1983; 258: 5319–5326
   Google Scholar
• Slater N. T., Carpenter D. O., Freedman J E., Snyder S. H. Vipoxin both activates and antagonizes three types of acetylcholine responses in Aplysia neurons. Brain Res. 1983; 278: 266–270
   Google Scholar
• Quik M. Binding characteristics of the bungarotoxin fraction II-S1 to rat brain membranes. Eur J. Pharmac 1985; 111: 239–244
   Google Scholar
• Gotti C., Omini C., Berti F., Clementi F. Isolation of a polypeptide from the venom of Bungarus multicinctus that binds to ganglia and blocks the ganglionic transmission in mammals. Neuroscience 1985; 15: 563–575
   PubMedGoogle Scholar
• Slater N. T., Carpenter D. O., Freedman J. E, Snyder S H. Dual effects of the snake venom polypeptide vipoxin on receptors for acetylcholine and biogenic amines in Aplysia neurons. Neuroscience 1985; 14: 723–733
   Google Scholar